NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for drug interaction


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Aileron Therapeutics Collaborators Publish In Vivo Research in Nature Showing Stapled Peptides Achieve the First Direct Inhibition of the Notch1 Transcription Factor Oncogene
2009 NOV 23 ... factors, that have not been addressable with current small molecule or biologic drug modalities. There are estimated to be more than 1,500 transcription factors in the human ... with current small molecule or biologic modalities, many features of the protein-protein interaction represented by Notch are similar to other transcription factor assemblies, giving us ...
Subject: Aileron Therapeutics
Price: $3.00
*
arGentis Acquires Rights to Rheumatoid Arthritis Therapy Entering Phase I Clinical Trial
2009 NOV 23 ... Autoimmune Diseases, Autoimmune Disorder, Clinical Trial Research, Clinical Trials, Drug Development, Immunology, Pharmaceuticals, Pre-Trials Research, Rheumatoid Arthritis, ... by which the specific peptide comprising ARG301 exerts its effect is not yet clear, the interaction of the APL/MHC complex with the TCR appears to play a key role in influencing the ...
Subject: arGentis Pharmaceuticals, LLC
Price: $3.00
*
Findings from Cleveland Clinic in molecular pharmaceutics reported
2009 NOV 25 ... when the peptide is conjugated to a carder system. HUVECs showed higher uptake of the drug with TAT-RNPs as compared to that with sc-TAT-RNPs or RNPs, suggesting that the ... from the changes in surface pressure (SIP) of the EMM as a function of time following interaction with NIPS, and the compression isotherm (pi-A) of the EMM lipid mixture in the presence ...
Subject: Molecular Pharmaceutics
Price: $3.00
*
New findings from J. Karagianis and co-authors in the area of schizophrenia published
2009 NOV 23 ... St., Malden 02148, MA, USA. Keywords: City:Toronto, Country:Canada, Adverse Drug Effect, Adverse Drug Event, Adverse Drug Reaction, Antipsychotic, Drugs, Mental Health, ... (CGI-SCH) severity scores, psychotropic medication use, adverse events, social interaction, housing and employment status, self-perceived health state (EuroQoL EQ-5D scale and ...
Subject: Schizophrenia
Price: $3.00
*
New findings in antimicrobials described by J. Jain and co-researchers
2009 NOV 23 ... that dose regimen of the SNIP formulation should ensure sustained release of the drug. To meet this requirement, a gel formulation containing SNP (S-gel) was prepared. The ... against Aspergillus niger and MIC of 25 mu g/mL against Candida albicans), When the interaction of SNP with commonly used antibiotics was investigated, the observed effects were ...
Subject: Antimicrobials
Price: $3.00
*
New findings in biochemistry described from Georgia State University
2009 NOV 27 ... information, contact J.J. Yang, Georgia State University, Dept. of Chemical, Center Drug Design & Advanced Biotechnology, Atlanta, GA 30303, USA.Publisher contact ... According to recent research from the United States, "Stromal interaction molecule 1 (STIM1) is responsible for activating the Ca2+ release-activated Ca2+ (CRAC) ...
Subject: Biochemistry
Price: $3.00
*
New veterinary medical science study findings reported from University of Agriculture
2009 NOV 23 ... concluded: "In clinical practice, therefore, KTZ may result in inhibition based drug-drug interaction with CYP3A Substrates in cat patients, whereas CIM and ERY are unlikely to lead to ...
Subject: Veterinary Medical Science
Price: $3.00
*
PanGenetics Announces Acquisition by Abbott of PG110 anti-NGF Antibody to Treat Chronic Pain
2009 NOV 23 ... firm focused on investing in life sciences companies, in particular in world-class drug discovery & development as well as med tech companies addressing substantial unmet ... which are involved in the growth and survival of nervous tissue. PG110 prevents the interaction of NGF with its receptors, which interaction plays a key role in pain transduction ...
Subject: PanGenetics
Price: $3.00
*
Research conducted at Harvard University has updated our knowledge about myeloma
2009 NOV 23 ... suggesting the need for further identification of factors mediating tumorigenesis and drug resistance. Using both in vitro and in vivo MM xenograft models, we show that ... Chauhan and colleagues published their study in Cancer Cell (Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target. ...
Subject: Myeloma
Price: $3.00
*
Research from Cleveland Clinic has provided new information about drug delivery
2009 NOV 23 ... "The transport of drugs or drug delivery systems across the cell membrane is a complex biological process, often ... their mechanisms of interactions with peptides, polymers, and nanocarriers. These interaction studies can be used to design and develop efficient drug delivery systems. Changes in ...
Subject: Drug Delivery
Price: $3.00
*
Research from Federal University provides new data about thermal science
2009 NOV 24 ... Solid-state characterization was carried out by DRIFT, SEM, and XRPD demonstrating the drug physicochemical properties including crystallinity. Drug-excipient compatibility studies ... Drug-excipient compatibility studies investigated by DSC have shown a possible physical interaction of the drug with magnesium stearate, microcrystalline cellulose and starch," wrote L.S. ...
Subject: Thermal Science
Price: $3.00
*
Researchers from University of Texas detail new studies and findings in the area of schizophrenia
2009 NOV 23 ... psychotic states that closely resemble schizophrenic symptoms and that persist after drug discontinuation. A large number of animal studies have used PCP and the NMDA antagonist ... i.p.): (1) working memory in a variable-delayed alternation task in a T-maze, (2) social interaction, and (3) motor activity in response to a (a) novel environment." Seillier ...
Subject: Schizophrenia
Price: $3.00
*
Researchers' work from Rockefeller University focuses on colon cancer
2009 NOV 23 ... receptor-dependent genes, including those coding for enzymes involved in phase 1 and 2 drug metabolism and oxidative stress responses, were induced. Oxidative stress was ... with semiquantitative morphometry. Transcriptome changes were translated into molecular interaction network maps and pathways. Pathways related to oxidative stress response; lipid, ...
Subject: Colon Cancer
Price: $3.00
*
Scientists at University of Catania release new data on life sciences
2009 NOV 23 ... a chiral and hydrophobic cavity, CDs have been extensively used as chiral selectors and drug delivery systems." "The functionalization both improve the CD ... the CD derivatives and their metal complexes. The metal ion assists the host-guest interaction often increasing the properties of CDs to act as chiral receptors," wrote F. Bellia and ...
Subject: Life Sciences
Price: $3.00
*
Studies conducted at G. Francesconi et al on sporotrichosis recently published
2009 NOV 23 ... "There are a few studies on the treatment of sporotrichosis. The standard drug used is itraconazole," scientists in Brazil report. "However, the use of ... in Brazil report. "However, the use of itraconazole is limited by its interaction with other drugs. To evaluate the effectiveness and safety of 250 mg terbinafine for the ...
Subject: Sporotrichosis
Price: $3.00
*
Studies from B.L. Anderson and co-researchers update current data on drug development
2009 NOV 23 ... "were asked about the information sources used when deciding to prescribe a new drug, interactions with sales representatives, views of representatives' value, and ... physicians tend to fall in the middle. Gender and age are not associated with industry interaction. Dispensing samples is associated with increased reliance on representatives when making ...
Subject: Drug Development
Price: $3.00
*
Studies from Technical University of Munich update current data on biophysics
2009 NOV 24 ... Yet, the underlying microscopic principles are still an enigma in cell biology and drug delivery. Here, we show that the extracellular matrix presents an effective ... particles are effectively trapped. However, by tuning the strength of this physical interaction of the particles with the biopolymer matrix, the microscopic mobility of formerly ...
Subject: Biophysics
Price: $3.00
*
Symbion Systems Announces the Introduction of a New Appliance for Secure and Streamlined Process Analytical Technology (PAT) Deployment
2009 NOV 23 ... Biotechnology Business, Biotechnology Company, FDA, Symbiontics Inc., U.S. Food and Drug Administration. This article was prepared by Biotech Business Week editors ... hard-drive and is ready for immediate deployment in a process environment. The interaction with the appliance is via a choice of a thin client or a client/server - allowing the ...
Subject: Biotechnology Business
Price: $3.00
*
Uppsala University publishes research in pharmacokinetics
2009 NOV 23 ... pharmacokinetic ethanol-drug formulation interaction. Thus, a pharmacokinetic ethanol-drug interaction is a very serious safety concern when substantially the entire dose from a controlled ...
Subject: Pharmacokinetics
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login